Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
pancreatic neoplasms/otok
Веза се чува у привремену меморију
Страна 1 од 72 резултати
[A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Gemcitabine mono-therapy was carried out in an unresectable pancreatic cancer. After six courses of treatment, pitting edema appeared and gradually became worse especially after gemcitabine infusion. Gemcitabine-induced edema was suspected after exclusion of other causes. Diuretics and steroids were
[Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Pancreatic adenocarcinoma is the fifth most common cause of cancer-related mortality in the world. The nucleoside analogue gemcitabine is the established standard therapy for advanced disease. Rare cases of gemcitabine-associated systemic capillary leak syndrome have been reported. Here, we present
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Single agent gemcitabine (GEM) is the standard treatment of pancreatic adenocarcinoma. Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor. Recent studies in human pancreatic tumor cell lines suggest an involvement of COX-2 in tumor-dependent angiogenesis and provide the rational
Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
We herein describe an 82-year-old patient who presented with proteinuria and systemic edema. He was diagnosed with minimal change disease (MCD) and was found to have stage III pancreatic cancer. He could not undergo surgical resection due to invasion to the celiac artery and he was thus treated with
Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Erlotinib-induced episcleritis in a patient with pancreatic cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Erlotinib is a relatively new anilinoquinazoline indicated for treatment of pancreatic cancer in combination with gemcitabine. It is a tyrosine kinase inhibitor that specifically targets epidermal growth factor receptor (EGFR), which is commonly overexpressed and/or mutated in solid
Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
We report a case of pseudocirrhosis arising in the setting of regression of liver metastases from pancreatic cancer. A 55-year-old asymptomatic woman presented to our clinic with newly diagnosed metastatic pancreatic cancer with extensive liver metastases. She underwent systemic chemotherapy with
Severe cholestatic liver failure associated with gemcitabine adjuvant monotherapy for pancreatic cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
We report a case of severe hepatic failure caused by gemcitabine hydrochloride (GEM) monotherapy after pancreaticoduodenectomy for advanced pancreatic cancer. A 73-year-old woman received GEM as an adjuvant chemotherapy. She suffered from progressive edema, fatigue, and jaundice after the third GEM
Laparoscopic Pancreaticoduodenectomy with Superior Mesenteric Vein Resection and Artificial Vascular Graft Reconstruction for Borderline Resectable Pancreatic Cancer
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Background: Laparoscopic pancreaticoduodenectomy (LPD) technique with artificial vascular graft reconstruction for patients with borderline resectable pancreatic cancer has been rarely reported since it is a very challenging technique.
A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
The aim of the study was to assess the clinical efficacy and toxicity of single-agent imatinib mesylate in patients with advanced, unresectable metastatic pancreatic cancer.
METHODS
Previously treated or untreated patients with histologically proven, unresectable pancreatic adenocarcinoma
Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Pleuropericardial effusion is an extremely rare complication of gemcitabine chemotherapy. The patient was a 56-year-old woman administered systemic chemotherapy with gemcitabine for local recurrence of pancreatic cancer and lymph node metastasis developing 4 years after pancreaticoduodenectomy. Four
[Erlotinib plus gemcitabine combination therapy in patients with unresectable advanced pancreatic cancer - a single-institution experience].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Pancreatic adenocarcinoma is one of the leading causes of cancer deaths in Japan. Erlotinib plus gemcitabine( GEM) combination therapy provided significant improvements in the overall and progression-free survival in a phase III trial in Canada and a phase II trial in Japan. As a result, this
Multicomponent Compression Bandaging Combined with Diuretic Therapy of Anasarca Secondary to Palliative Chemotherapy: A Case Report.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Background: Although decongestive physiotherapy combined with diuretics may be efficient in limb edemas, no such therapy has been described in the context of anasarca. Case Description: A bedbound 62-year-old man with stage IV pancreatic cancer, presenting with progressing severe
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To date, no standard regimen for salvage chemotherapy after gemcitabine (Gem) failure has been defined for patients with advanced pancreatic cancer (PC). Oral capecitabine (Cap) has shown promising activity in first-line chemotherapy trials in PC patients.
METHODS
Within a prospective
[A Case of Cystoid Macular Edema Secondary to Albumin-Bound Paclitaxel Therapy].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A 73-year-old woman diagnosed with unresectable pancreatic cancer received weekly gemcitabine(GEM)plus albuminbound paclitaxel(nab-PTX)therapy. Four months after nab-PTX therapy was initiated, she presented with a rapidly decreasing vision in her left eye at an ophthalmology clinic. On admission,
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
